Exogenous Cushing's syndrome as a serious side-effect of therapy with ritonavir an inhaled fluticasone

Inhalation of fluticasone is usually devoid of systemic side-effects. The authors describe a case of a young HIV positive woman treated concomitantly with fluticasone and inhibitors of HIV protease ritonavir and lopinavir in which developed a serious endocrine side-effect - an iatrogenic Cushing's syndrome. Plasma concentration of cortisol < 5.5 nmol/l was very low (norm 250-650 nmol/l) and plasmatic ACTH was even not detectable. The administration of fluticasone and both inhibitors of HIV protease was stopped and substitution therapy with decreasing dose of hydrocortisone was initiated. Twenty weeks later resolved both clinical and laboratory symptoms of Cushing's syndrome, and the substitution therapy with hydrocortisone was terminated. Two years later became the patient pregnant and gave birth to a healthy child.

Medienart:

Artikel

Erscheinungsjahr:

2011

Erschienen:

2011

Enthalten in:

Zur Gesamtaufnahme - volume:17

Enthalten in:

Klinicka mikrobiologie a infekcni lekarstvi - 17(2011), 3 vom: 01. Juni, Seite 103-5

Sprache:

Tschechisch

Weiterer Titel:

Exogenni Gushinguv syndrom jako zavazny nezadouci ucinek lecby ritonavirem a inhalacnim flutikazonem

Beteiligte Personen:

Machala, Ladislav [VerfasserIn]
Kréze, Alexander [VerfasserIn]
Jilich, David [VerfasserIn]
Rozsypal, Hanuš [VerfasserIn]

Themen:

Androstadienes
Anti-Allergic Agents
CUT2W21N7U
Case Reports
English Abstract
Fluticasone
HIV Protease Inhibitors
Journal Article
O3J8G9O825
Ritonavir

Anmerkungen:

Date Completed 30.08.2011

Date Revised 19.11.2015

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM210153709